ROMIDEPSIN for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 13 adverse event reports in the FDA FAERS database where ROMIDEPSIN was used for Off label use.
Most Reported Side Effects for ROMIDEPSIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Peripheral t-cell lymphoma unspecified | 102 | 8.0% | 73 | 18 |
| Nausea | 91 | 7.1% | 11 | 33 |
| Death | 90 | 7.0% | 90 | 10 |
| Thrombocytopenia | 90 | 7.0% | 23 | 29 |
| Pyrexia | 77 | 6.0% | 18 | 49 |
| Drug ineffective | 69 | 5.4% | 19 | 25 |
| Anaemia | 61 | 4.8% | 14 | 21 |
| Electrocardiogram qt prolonged | 61 | 4.8% | 5 | 3 |
| Platelet count decreased | 60 | 4.7% | 22 | 24 |
| Vomiting | 57 | 4.5% | 5 | 28 |
| Fatigue | 55 | 4.3% | 7 | 21 |
| Product storage error | 53 | 4.1% | 0 | 0 |
| Atrial fibrillation | 52 | 4.1% | 9 | 23 |
| Neutropenia | 49 | 3.8% | 9 | 10 |
| Malignant neoplasm progression | 45 | 3.5% | 17 | 8 |
Other Indications for ROMIDEPSIN
Peripheral t-cell lymphoma unspecified (390)
Product used for unknown indication (171)
Angioimmunoblastic t-cell lymphoma (140)
Cutaneous t-cell lymphoma (101)
T-cell lymphoma (81)
Mycosis fungoides (48)
Breast cancer metastatic (37)
Lymphoma (30)
Acute myeloid leukaemia (29)
Adult t-cell lymphoma/leukaemia (20)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)